default author photo

Jianmin Yang

affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

92

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Efficacy and Safety of Sintilimab for Relapsed/Refractory Classic Hodgkin Lymphoma: A Multicentre, Single-Arm Phase II Study (ORIENT-1)

Number of pages: 118 Posted: 24 Sep 2018
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology
Downloads 92 (730,864)

Abstract:

Loading...

PD-1, classic Hodgkin's Lymphoma, relapsed/refractory, ORIENT-1